Navigation Links
ERT Reports First Quarter 2011 Operating Results
Date:5/2/2011

er of 2011 compared to 11.6% for the fourth quarter of 2010 and 12.6% a year ago.  Non-GAAP operating income margin percentage was 17.3% in the first quarter of 2011 compared to 18.5% for the fourth quarter of 2010 and 16.0% a year ago.
  • GAAP net income was $3.1 million, or $0.06 per diluted share, in the first quarter of 2011 compared to $4.1 million, or $0.08 per diluted share, in the fourth quarter of 2010 and $1.8 million, or $0.04 per diluted share, a year ago.  Non-GAAP net income was $4.5 million, or $0.09 per diluted share, in the first quarter of 2011 compared to $6.1 million, or $0.12 per diluted share, in the fourth quarter of 2010 and $2.2 million, or $0.05 per diluted share, a year ago.

  • Cash flow from operations was $5.0 million in the first quarter of 2011, compared to $17.1 million in the fourth quarter of 2010 and $5.3 million a year ago.

  • Cash and short-term investments totaled $29.7 million at March 31, 2011 compared to $30.4 million on December 31, 2010.  ERT had $21.0 million in long-term debt as of March 31, 2011 and December 31, 2010.

  • New bookings were $71.8 million in the first quarter of 2011 compared to $58.9 million for the fourth quarter of 2010 and $43.3 million a year ago.  

  • The gross book-to-bill ratio was 1.7 in the first quarter of 2011 compared to 1.3 in the fourth quarter of 2010 and 2.0 a year ago.  

  • Backlog was $318.6 million as of March 31, 2011 compared to $302.9 million as of December 31, 2010 and $182.7 million a year ago (which did not include RS).  The annualized cancellation rate was 24.6% in the first quarter of 2011 compared to 16.6% in the fourth quarter of 2010 and 21.3% a year ago.  

  • "We are very pleased with the record $71.8 million of bookings reported in this quarter," commented Dr. Joel Morganroth.  "This was driven by strong bookings using our integrated so
    '/>"/>

    SOURCE ERT
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    2. Spherix Reports Second Quarter Earnings
    3. Tapestry Reports Second Quarter 2007 Results
    4. Callisto Reports on Second-Quarter 2007 Milestones
    5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
    6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    9. Biopure Reports on Meeting with the FDA
    10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
    11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... Investor-Edge has initiated coverage on the ... Pharma PLC (NASDAQ: HZNP ), Endocyte Inc. (NASDAQ: ... JNJ ), and Theravance Inc. (NASDAQ: THRX ). ... http://investor-edge.com/register . On Tuesday, November 25, 2014, ... Jones Industrial Average edged 0.02% lower, to finish the day ...
    (Date:11/26/2014)... , November 26, 2014 A ... of the organ protrudes through the wall of a weak ... area at birth are some of the causes of hernias. ... hiatal, femoral, and incisional. An inguinal hernia is when part ... umbilical hernia is found in the area of the umbilicus. ...
    (Date:11/26/2014)... 2014  Aridis Pharmaceuticals, Inc., a biopharmaceutical company ... infectious diseases, announced today the addition of ... opinion leader in the areas of pneumonia and ... Founder and Chief Executive Officer, Vu ... extensive experience investigating bacterial toxins and key mechanisms ...
    Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
    ... dependent on opioids (narcotic pain relievers) for pain management ... difficulty recovering, a study recently published in the Journal ... found. These patients tend to have longer hospital stays, more ... likely to need additional procedures, than patients who are not ...
    ... Nov. 11, 2011 It,s a well known metric in ... to fill a prescription after initially receiving a sample from ... evolving as the traditional sampling conduit - sales reps - ... counts. In this environment, many pharmaceutical companies ...
    Cached Medicine Technology:Take Care with Pain Meds 2Take Care with Pain Meds 3Current Trends and Future Directions in Physician E-Sampling Programs for the Pharmaceutical Industry 2
    (Date:11/27/2014)... New York, New York (PRWEB) November 27, 2014 ... http://www.risperdallawsuit2014.com/ ) have been filed in a ... Bernstein Liebhard LLP reports. , Documents recently ... show 1,079 records included in the state proceeding, ... treat schizophrenia, bipolar disorder and other psychiatric conditions. ...
    (Date:11/27/2014)... Dennis Thompson HealthDay Reporter ... experimental Ebola vaccine appears to be safe and produces an ... virus, according to early clinical trial results reported by the ... phase I clinical trial for the vaccine paves the way ... Liberia and Sierra Leone as early as January, said Dr. ...
    (Date:11/27/2014)... (PRWEB) November 27, 2014 The founders of ... stylish, comfortable and high functioning compression socks, are proud to ... socks use an innovative Gradient Pressure (TM) knitting technology that ... , VIM & VIGR’s commitment to adding flair and style ... just functional recently caught the eye of a writer at ...
    (Date:11/27/2014)... New York, New York (PRWEB) November 27, 2014 ... behalf of individuals who were allegedly injured by the ... court, where a federal litigation is looking ahead to ... , According to a Scheduling Order issued earlier ... take place on December 16th at 10:00 a.m. Items ...
    (Date:11/27/2014)... “Wekho” was featured on NewsWatch as part of ... applications on the iOS, Android, and Windows markets. Andrew Tropeano, ... app review and shared with viewers how it ... interesting new way to travel and experience the world has ... called Wekho and it’s a free geolocation app that lets ...
    Breaking Medicine News(10 mins):Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2
    ... indelible impact on the lives of many in 2004 and ... ,The most recent data enabled by the AMA ... to CVD, at 406 deaths per 100,000 people. Minnesota portrayed ... 100,000 people. ,The statistics also pointed out ...
    ... A comprehensive review published in the January 1st issue ... diseases// characterized by selective cell loss, narcolepsy may be ... in genetically susceptible individuals - a possible contradiction to ... responses and stressful life events are factors that may ...
    ... 60-year-old woman has brought about a revolution in the lives ... determined retiree from Hong Kong, decided one day to live ... there. That momentous decision has made a huge difference to ... is the only nurse at the Tanshan Leper Rehabilitation Village ...
    ... Chandigarh: Children, pregnant and lactating women and adolescent ... from the state government for their nutritional needs. ... Monday announced enhanced quantum for supplementary nutritional needs ... Development Service (ICDS) scheme. ,She said ...
    ... down on calories could help in preventing or delaying ... University of Alabama at Birmingham suggest that a key ... body composition (being lean or obese) and whether calories ... the risk of cancer., ,During a study conducted ...
    ... your New Year resolutions, The Alliance for Aging Research// has ... both physical as well as mental exercise to stay fighting ... Alliance for Aging Research said, "There is a lot we ... or lessen the cognitive decline that often comes with aging. ...
    Cached Medicine News:Health News:Narcolepsy May Be Caused By Environmental Exposures: Study 2Health News:A ‘Good Samaritan’ to the Aid of Lepe 2Health News:A ‘Good Samaritan’ to the Aid of Lepe 3
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: